DE VINCENTIS, ANTONIO
 Distribuzione geografica
Continente #
AS - Asia 5.659
NA - Nord America 1.873
EU - Europa 943
SA - Sud America 282
AF - Africa 48
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.818
Nazione #
SG - Singapore 4.271
US - Stati Uniti d'America 1.791
CN - Cina 586
IT - Italia 512
HK - Hong Kong 273
BD - Bangladesh 232
BR - Brasile 206
VN - Vietnam 121
FR - Francia 114
GB - Regno Unito 99
DE - Germania 67
IN - India 50
CA - Canada 39
MX - Messico 33
AR - Argentina 31
NL - Olanda 29
FI - Finlandia 19
TR - Turchia 19
PL - Polonia 18
CZ - Repubblica Ceca 17
ID - Indonesia 17
JP - Giappone 15
EC - Ecuador 14
ZA - Sudafrica 14
UA - Ucraina 11
AU - Australia 10
EG - Egitto 10
IQ - Iraq 10
KE - Kenya 9
PK - Pakistan 9
PT - Portogallo 8
CO - Colombia 7
ES - Italia 7
RO - Romania 7
RU - Federazione Russa 7
SA - Arabia Saudita 7
CL - Cile 6
PE - Perù 6
PH - Filippine 6
UZ - Uzbekistan 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
MY - Malesia 4
NP - Nepal 4
CH - Svizzera 3
HN - Honduras 3
IE - Irlanda 3
LB - Libano 3
LT - Lituania 3
MD - Moldavia 3
PY - Paraguay 3
SE - Svezia 3
TN - Tunisia 3
AT - Austria 2
AZ - Azerbaigian 2
BH - Bahrain 2
BY - Bielorussia 2
DZ - Algeria 2
ET - Etiopia 2
IR - Iran 2
JM - Giamaica 2
JO - Giordania 2
KR - Corea 2
RS - Serbia 2
SN - Senegal 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BE - Belgio 1
BF - Burkina Faso 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CR - Costa Rica 1
CY - Cipro 1
FK - Isole Falkland (Malvinas) 1
GN - Guinea 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
KH - Cambogia 1
KI - Kiribati 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MA - Marocco 1
MS - Montserrat 1
MU - Mauritius 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 8.817
Città #
San Jose 576
Singapore 433
Ashburn 362
Rome 327
Hong Kong 270
Hefei 183
Beijing 164
Boardman 91
Lauterbourg 88
Dallas 87
London 67
Shanghai 61
Los Angeles 53
Santa Clara 50
Ho Chi Minh City 47
New York 45
Munich 39
Council Bluffs 31
Mexico City 30
Hanoi 24
Chicago 22
Amsterdam 18
San Francisco 18
São Paulo 17
Brno 16
Milan 15
Orem 15
Turku 15
Boston 14
Buffalo 13
Pune 13
Seattle 13
Paris 12
Toronto 12
Warsaw 12
Tokyo 11
Washington 11
Brooklyn 10
Montreal 10
Naples 10
Chennai 8
Lisbon 8
Manchester 8
Nairobi 8
Rio de Janeiro 8
Boydton 7
Cairo 7
Charlotte 7
Haiphong 7
Redmond 7
Frankfurt am Main 6
Guangzhou 6
Johannesburg 6
Las Vegas 6
Pasadena 6
Quito 6
Turin 6
Bucharest 5
Canberra 5
Guayaquil 5
Lahore 5
Riyadh 5
Bologna 4
Curitiba 4
Da Nang 4
Hangzhou 4
Helsinki 4
Istanbul 4
Kochi 4
Melbourne 4
New Delhi 4
Poplar 4
Tashkent 4
Trieste 4
Ascoli Piceno 3
Bari 3
Bedford 3
Belo Horizonte 3
Buenos Aires 3
Campinas 3
Curvelo 3
Denver 3
Dublin 3
Genoa 3
Goiânia 3
Helena 3
Houston 3
Jakarta 3
José C. Paz 3
Juneau 3
Krasnodar 3
Lima 3
Medellín 3
Miami 3
Newark 3
Palermo 3
Perugia 3
Phoenix 3
Rondonópolis 3
Salvador 3
Totale 3.573
Nome #
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 247
Management of hip fracture in the older people: rationale and design of the Italian consensus on the orthogeriatric co-management 238
A Functional and Immunologic Point of View on Corneal Endothelial Transplantation: A Systematic Review and Meta-Analysis 233
Chronic cough in adults: recommendations from an Italian intersociety consensus 229
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 227
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 224
Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 218
Combined evaluation of aminotransferases improves risk stratification for overall and cause-specific mortality in older patients 214
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 213
The hepatic expression of lysosomal acid lipase (LAL) is reduced in NAFLD patients, and associated with features of genetically determined LAL deficiency and NAFLD activity score 208
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 203
Assessment of liver function by the exhaled breath-print during chronic liver disease 202
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study 196
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 172
Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography 169
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery 153
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 138
Orthogeriatric co-management for the care of older subjects with hip fracture: recommendations from an Italian intersociety consensus 137
Return to Sport after Anatomic and Reverse Total Shoulder Arthroplasty in Elderly Patients: A Systematic Review and Meta-Analysis 135
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 135
Gut Microbiota and Related Electronic Multisensorial System Changes in Subjects With Symptomatic Uncomplicated Diverticular Disease Undergoing Rifaximin Therapy 133
Exhaled breath analysis in hepatology: State-of-the-art and perspectives 132
Acoustic Radiation Forced Impulse of the Liver and the Spleen, Combined with Spleen Dimension and Platelet Count in New Ratio Scores, Identifies High-Risk Esophageal Varices in Well-Compensated Cirrhotic Patients 131
A challenging alfa-fetoprotein in a cirrhotic patient 130
Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease 128
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease 121
Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older people 119
Authors' Reply to Brunetti et al. "Potentially Inappropriate Medications, Drug-Drug Interactions, and Anticholinergic Burden in Elderly Hospitalized Patients: Does an Association Exist with Post-Discharge Health Outcomes?" 115
Appropriateness of direct oral anticoagulant prescribing in older subjects with atrial fibrillation discharged from acute medical wards 114
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 114
ALT levels are associated with metabolic parameters and age in a large real-life population. 111
Breathprinting of liver diseases 109
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 108
The PNPLA3 rs738409 variant can increase the risk of liver toxicity in multiple sclerosis patients treated with beta-interferon 107
Analysis of volatile organic compounds: an innovative approach to heart failure characterization in older patients 107
A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores 106
Association between clinical scores of liver fibrosis and adverse non-hepatic outcomes: The key in the holistic vision of the patient 104
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis 98
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 90
Essays on quality of therapy and impact of comorbidities in older hospitalized subjects 90
Prevalence, risk factors, and treatment of anemia in hospitalized older patients across geriatric and nephrological settings in Italy 87
Clinical outcomes and phenotypes of respiratory failure in older subjects admitted to an acute care geriatric hospital ward 86
Length of Hospital Stay after Total Knee Arthroplasty: A Correlation Study on 1200 Patients 75
Non‐invasive assessment of hepatic steatosis by ultrasound‐derived fat fraction in individuals at high‐risk for metabolic dysfunction‐associated steatotic liver disease 71
Hepatocellular carcinoma in alcoholic liver disease: current management and recent advances 68
Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management 67
The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients 65
Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis 65
Potentially inappropriate medications, drug–drug interactions, and anticholinergic burden in elderly hospitalized patients: does an association exist with post-discharge health outcomes? 64
Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank 63
Poor accuracy and sustainability of the first-step FIB4 EASL pathway for stratifying steatotic liver disease risk in the general population 62
Incidence and Outcome of Pneumomediastinum in Non-ICU Hospitalized COVID-19 Patients 61
Prevalence, clinical characteristics, and disease burden of chronic cough in Italy: a cross-sectional study 60
Deprescribing psychoactive drugs in older orthogeriatric patients: findings from the GIOG2.0 Italian survey 58
Return to Sport Activity in the Elderly Patients after Unicompartmental Knee Arthroplasty: A Systematic Review and Meta-Analysis 58
Correction: Deprescribing psychoactive drugs in older orthogeriatric patients: findings from the GIOG2.0 Italian survey 58
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 56
Reply to the Letter: “Low levels of transaminase and mortality risk in older people with special reference to sarcopenia” 56
Impact of Low Muscle Mass and Low Muscle Strength According to EWGSOP2 and EWGSOP1 in Community-Dwelling Older People 54
Rate of non-response to ursodeoxycholic acid in a large real-world cohort of primary biliary cholangitis patients in Italy 54
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease 53
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 53
Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens 52
Hepatic complications of bariatric surgery : the reverse side of the coin 52
Low Alanine Aminotransferase Levels in the Elderly Population: Frailty, Disability, Sarcopenia, and Reduced Survival 52
Preoperative and Perioperative Predictors of Length of Hospital Stay after Primary Total Hip Arthroplasty-Our Experience on 743 Cases 50
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 49
Individuation of presence and combination of genetic risk factors may help to refine the risk for most severe forms of NAFLD 49
NAFLD FIBROSIS SCORE IS ASSOCIATED WITH CARDIOVASCULAR DISEASE IN PATIENTS UNDERGOING CORONAROGRAPHY 48
Predicting risk of declining functional ability in community-dwelling older people 47
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 46
E-nose discriminative ability within a highly homogeneous sample of respiratory diseases 46
Sleep disorders during the COVID-19 pandemic: Results from the second phase of web-based EPICOVID19 study 45
Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosis 45
Microarray-based Detection of Critical Overexpressed Genes in the Progression of Hepatic Fibrosis in Non-alcoholic Fatty Liver Disease: A Protein-protein Interaction Network Analysis 44
Effect of sibutramine on plasma C-reactive protein, leptin and adiponectin concentrations: a systematic review and meta-analysis of randomized controlled trials 44
Inborn and acquired risk factors for severe liver disease in Europeans with type 2 diabetes from the UK Biobank 44
Screening of obstructive sleep apnea syndrome by electronic-nose analysis of volatile organic compounds 43
Voltammetric analysis for distinguishing portal hypertension-related from malignancy-related ascites: A proof of concept study 43
Molecular and histological traits of reduced lysosomal acid lipase activity in the fatty liver 43
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: Analysis of the REPOSI registry 41
Haemorrhoidal disease in severe portal hypertension: a combined approach with transjugular intrahepatic portosystemic shunt (TIPS) and transanal haemorrhoidal dearterialization (THD) 41
The authors reply 41
Neurotrophic keratopathy: pros and cons of current treatments 39
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 39
Genetic variants in the MTHFR are not associated with fatty liver disease. 39
Reply 38
Platelet count may impact on lysosomal acid lipase activity determination in dried blood spot 36
Long noncoding RNAs in nonalcoholic fatty liver disease and liver fibrosis: state-of-the-art and perspectives in diagnosis and treatment 34
Liver Cirrhosis is Characterized by an Acquired Lysosomal Acid Lipase Deficiency Independent from the Etiology of Liver Disease 33
Prevalence of anti-hepatitis C positivity in a nursing home: a hitherto unrecognized submerged population 31
Reply 30
Prevalence of patatin-like phospholipase domain containing 3 (PNPLA3) rs738409 C/G polymorphism in patients with bona-fide post-NASH cirrhosis 30
A noninvasive strategy for multi-disease diagnosis via multi-sensor platform: integrative analysis of five years of exhaled breath-based diagnostics for seven diseases 28
PhenoAge and PhenoAgeAccel do not outperform chronological age in predicting physical performance decline or mortality in community-dwelling older adults 1
Totale 8.895
Categoria #
all - tutte 46.627
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.627


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022174 0 0 10 0 1 4 0 2 54 0 0 103
2022/202399 1 1 8 2 10 4 36 9 5 7 16 0
2023/2024316 11 27 15 36 39 120 0 10 4 16 12 26
2024/20254.616 57 25 87 19 75 96 87 25 217 291 1.633 2.004
2025/20263.688 295 148 222 344 132 202 956 214 252 329 307 287
2026/20272 2 0 0 0 0 0 0 0 0 0 0 0
Totale 8.895